Liver transplantation recovers hepatic N-glycosylation with persistent IgG glycosylation abnormalities: Three-year follow-up in a patient with phosphomannomutase-2-congenital disorder of glycosylation-Reference-Cited by-同舟云学术

Liver transplantation recovers hepatic N-glycosylation with persistent IgG glycosylation abnormalities: Three-year follow-up in a patient with phosphomannomutase-2-congenital disorder of glycosylation

Published:2023-04 Issue:4 Volume:138 Page:107559
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Tahata Shawn,Weckwerth Jody,Ligezka Anna,He Miao,Lee Hee Eun,Heimbach Julie,Ibrahim Samar H.,Kozicz Tamas,Furuya Katryn,Morava Eva

Funder

National Institute of Neurological Disorders and Stroke

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference40 articles.

1. Recognizable phenotypes in CDG;Ferreira;J. Inherit. Metab. Dis.,2018

2. Epidemiology of congenital disorders of glycosylation (CDG)—overview and perspectives;Piedade;J. Rare Dis.,2022

3. Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?;Witters;Genet. Med.,2018

4. Nutrition interventions in congenital disorders of glycosylation;Boyer;Trends Mol. Med.,2022

5. Should patients with Phosphomannomutase 2-CDG (PMM2-CDG) be screened for adrenal insufficiency?;Čechová;Mol. Genet. Metab.,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of congenital disorders of glycosylation: An overview;Molecular Genetics and Metabolism;2024-09

2. Frontiers in congenital disorders of glycosylation consortium, a cross-sectional study report at year 5 of 280 individuals in the natural history cohort;Molecular Genetics and Metabolism;2024-08

3. Liposome-encapsulated mannose-1-phosphate therapy improves global N-glycosylation in different congenital disorders of glycosylation;Molecular Genetics and Metabolism;2024-06

4. A complement C4–derived glycopeptide is a biomarker for PMM2-CDG;JCI Insight;2024-04-08

5. Expanding the phenotype and metabolic basis of ATP6AP2-congenital disorder of glycosylation in a Chinese patient with a novel variant c.185G>A (p.Gly62Glu);Frontiers in Genetics;2023-11-22